CLM vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CLM presents a complex profile with a Piotroski F-Score of 4/9, indicating stable but not strong financial health. While the stock is significantly undervalued relative to its Graham Number ($12.85) and Intrinsic Value ($32.16), this value is offset by a critical dividend payout ratio of 134.12%, suggesting the current yield is unsustainable. Despite strong historical 1-year and 3-year price appreciation, the current technical trend is completely bearish (0/100), and the low current ratio (0.58) indicates potential liquidity constraints.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
CLM vs JPM: Head-to-Head Comparison
This page compares Cornerstone Strategic Investment Fund, Inc. (CLM) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.